(PDF) Week 4 Response Predicts Sustained Virological

Week 4 Response Predicts Sustained Virological Response to All-Oral Direct-Acting Antiviral-Based Therapy in Cirrhotic Patients With Hepatitis C Virus Genotype 3 Infection

Clinical Microbiology and Infection - United Kingdom

doi 10.1016/j.cmi.2016.12.034

Full Text

Open PDF

Abstract

Available in full text

Date

June 1, 2017

Authors

J.C. Alados-Arboledas

Publisher

Elsevier BV

Amanote Research

Week 4 Response Predicts Sustained Virological Response to All-Oral Direct-Acting Antiviral-Based Therapy in Cirrhotic Patients With Hepatitis C Virus Genotype 3 Infection

Clinical Microbiology and Infection - United Kingdom

doi 10.1016/j.cmi.2016.12.034

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Interferon-Ë Rs12979860CC Genotype Predicts Sustained Virological Response to Therapy in Patients With Chronic Hepatitis C Genotype 4 but Enhances Hepatic Fibrosis

Real-World Effectiveness and Predictors of Sustained Virological Response With All-Oral Therapy in 21,242 Hepatitis C Genotype-1 Patients

Oral Direct-Acting Antiviral Therapy for Hepatitis C

Prediction of Sustained Virological Response to Telaprevir/Simeprevir-Based Triple Therapy in Patients With Genotype 1 Hepatitis C Virus Using Super-Early Viral Response Within 2 Weeks

Hepatitis C Virus: Five-Year Follow-Up of Patients With Sustained Virological Response

Risk of Hepatocellular Carcinoma After Sustained Virological Response in Veterans With Hepatitis C Virus Infection

Sustained Virological Response and Its Treatment Predictors in Hepatitis C Virus Genotype 4 Compared to Genotypes 1, 2, and 3: A Meta-Analysis

Shear Wave Elastography Predicts Hepatocellular Carcinoma Risk in Hepatitis C Patients After Sustained Virological Response

Reinfection With Hepatitis C Virus Following Sustained Virological Response in Injection Drug Users